Search

Your search keyword '"Soumerai, Jacob D."' showing total 8 results

Search Constraints

Start Over You searched for: Author "Soumerai, Jacob D." Remove constraint Author: "Soumerai, Jacob D." Publisher american association for cancer research (aacr) Remove constraint Publisher: american association for cancer research (aacr)
8 results on '"Soumerai, Jacob D."'

Search Results

1. Supplementary Data from Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach

2. Data from Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach

3. Supplementary Figure Legends from The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma

4. Supplementary Data from Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach

5. Supplementary Figure S1 from The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma

6. Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach

7. The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma

8. Lenalidomide and Rituximab in Waldenstrom's Macroglobulinemia

Catalog

Books, media, physical & digital resources